Engineered immune cells show promise in Hard-to-Treat leukemia
NCT ID NCT06481735
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of CAR-T cell therapy for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to treatment. The therapy uses donor immune cells that are modified to target cancer cells and last longer in the body. The goal is to see if it is safe and effective, with 30 participants expected to enroll.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biotherapeutic Department of Chinese PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, 100853, China
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Hematology, Chinese PLA General Hospital
RECRUITINGBeijing, China
Contact
Contact
Contact
Contact
Contact
-
Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College
RECRUITINGChangzhi, China
Contact
-
Department of Hematology, Peking Union Medical College Hospital
NOT_YET_RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Hematology, Tianjin First Central Hospital
RECRUITINGTianjin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Immune Cell Therapy Center, Blood Disease Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, China
Contact